Risk factors for ovarian cancer and early-onset breast cancer in Mongolia

Objective: To determine if there are founder BRCA1 mutations in the Mongolian population.

Methods: Seventeen women with ovarian cancer, 14 women with premenopausal breast cancer and one woman with both cancer types were interviewed to obtain family history, and hormonal, reproductive and environment risk factor information. Blood was collected for DNA analysis from these women to determine the frequency of BRCA1 and BRCA2 mutations in Mongolia.

Results: Two patients had two first-degree relatives with cancer and nine women had one first degree relative with cancer. Two women had the unique BRCA1 mutation previously described. These two women were not related but their parents were from the same tribe and they lived in the same imak (province). Only one other patient was of this tribal background and from the same region; however, she did not have the BRCA1 mutation.

Conclusion: A substantial proportion of Mongolian woman with ovarian cancer or early-onset breast cancer may be due to a founder BRCA1 mutation 3452delA.

Ovarian cancer: Breast cancer; Risk factors; Mongolia

[1] Luvsandor」B.:"Epidemiology of Ovarian Cancer Cases of Mongolia". Salzburg,Cornell Seminars. 1999.

[2] Elit L., Jack E., Kwan E.. Baigal G., Narod S. A: "Unique BRCA 1 mutation identified in Mongolia". Internal. J. c)fGynecol. Oncol., 2001, 11(3), 241.

[3] Szabo C, King M.: "Population genetics of BRCA I and BRCA2". Am. J. Hum. Genet., 1997, 60, 1013.

[4] Berman D.,W agner-Costalos J.,S chultz D. C.,L ynch H. T.. Daly M., Godwin A. K.: "Two distinct origins of a common BRCAI mutation in breast-ovarian cancer families: a genetic study of 15 l 85de!AG-mutation kindreds". Am. J. Hum. Genet., 1996, 58, 1166.

[5] Berman D.,C ostalas J.,S chultz D. C.,G rana G.,D aly M.. Godwm A. K.: "A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and nonJewish individuals". Cancer Research., 1996. 56, 3409.

[6] Fitzgerald M. G.. Macdonald D. J., Krainer M. et al.: "Germ-lme BRCA I mutations in Jewish and non-Jewish women with early onset breast cancer". N.E.J.M., 1996, 334, 143.

[7] Friedman L. S.,S zabo C.,O stermeyer E. et{1I.: "Novel inherited mutations and variable expressivity of BRCA I alleles, including the founder mutation l 85de!AG in Ashkenazi Jewish families". Am..l. Hum. Genet., 1995, 57, 1284.

[8] Levy-Lahad E., Catane R., Eisenberg S. et al.: "Founder BRCA 1 and BRCA2 mutations in Ashkena7i Jews in Israel: frequency and differential pcnetrance in ovarian cancer and in Breast-Ovarian cancer families". Am. J. Hum. Genet., 1997, 60, 1059.

[9] Modan B., Gak E., Bar Sade-Bruchim R. et al.: "High frequency of BRCAI 185de!AG mutation in ovarian cancer in Israel". J.A.M.A. 1996, 276, 1823.

[10] Neuhausen S., Gilewski T., Norton Let al.: "Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer". Nuture Genet., 1996, 13, 126.

[11] Oddoux C., Struewing J.P., Clayton C. M. et al.:'The carrier frequcncy of the BRCA2 6174de!T mutation among Ashkenazi Jewish individuals is approximately I%. Nature Genet., 1996. 14, 188.

[12] Struewing J. P., Abeliovich D.. Peretz T. et al.: "The carrier frequency of the BRCAI 185de!AG mutation is approximately I percent in Ashkenazi Jewish individuals". Nature Genet., 1995, ll. 198.

[13] Tonin P., Serova O., Lenoir G. M. et al.: "BRCAI mutations in Ashkenazi Jewish women". Am. J. Hum. Genet., 1995, 57, 189.

[14] Tonin P., Weber B., Offit K. et al.: "Frequency of recurrent BRCAI and BRCA2 mutations in Ashkenzi Jewish breast cancer families". Nature Med.. 1996, 2, 1179.

[15] Peelen T., van Vliet M., Petrij-Bosch A. et al.: "A high proportion of novel mutations in BRCAl with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families" Am. J. Hum. Genet. 1997, 60, 1041.

[16] Petrij-Bosch A., Peelen T., van Vliet M. et al.: "BRCAI genomic deletions are major founder mutation、in Dutch breast cancer patients". Nature Genet., 1997, 17, 341.

[17] Simard J., Ton in P., Durocher F. et al.: ''Common origins of BRCA I mutations in Canadian breast and ovarian cancer families". Nature Genet., 1994, 8, 392.

[18] Tonin P.. MesMasson A. M., Futreal P. A. et al.: "Founder BRCA and BRCA2 mutations in french Canadian breast and ovarian cancer families". Am. J. Hum. Genet., 1998, 6., 1341.

[19] Gayther S. A.. Harrington P., Russell P., Kharkevich G., Garkavtseva R. F., Ponder B. A. J.: "Frequently occurring germ-line mutations of the BRCAl gene in ovarian cancer families from Russia". Am. J. Hum. Genet.. 1997, 60, 1239.

[20] De Benedetti V. M. G., Radice P.,M ondini P. et al.:" Screening for mutations in exon 11 of the BRCAl gene in 70 Italian breast and ovarian cancer patients by protein truncation test". Oncogene,1996, 13, 1353.

[21] Caligo A., Ghimenti C.. Cipollini G. et al.:''BRCAl germhne mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations“ . Oncogene 1996, 13, 1483.

[22] Montagna M.. Santacatterina M.、Corneo B. et al.: "Tdentification of seven new BRCA 1 germline mutations in Italian breast and breast/ovarian cancer families". Cancer Res., 1996, 56, 5466.

[23] Gudmundsson J., Johanne、dottir G., Arason A. et al.: "Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA3 haplotype". Am. J, Hum Genet., 1996, 58, 749.

[24] Johannesdottir G., Gudmundsson J,, Bergthorsson J. T. et al.: "High prevalence of the 999del5 mutation in Icelan? breast and ovarian cancer patients". Cancer Res., 1996, 56, 3663.

[25] Thorlacius S., Olafdottir G., Tryggvadottir L. et al.: "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes". Nature Genet., 1996, 13, 117,

[26] Inoue R., Fukutomi T., Ushijima T., Matsumoto Y., Sugimura T., Nagao M.: "Gennline mutation of BRCAl in Japanese Breast Cancer Families". Cancer Res,, 1995, 55, 3521.

[27] Katagiri T., Emi M., Ito I. et al.: "Mutations in the BRCAI gene in Japancse breast cancer patients". Human Mut., 1996, 7, 334.

[28] Hamann U., Brauch H., Garvin A. M., Bastert G., Scott R. L.: "German Family study on Hereditary Breast and/or Ovarian cancer: Germline mutation analysis of the BRCA 1 gene". Genes, Chromosomes and Cancer, 1997, 18, 126.

[29] Jandrig B., Grade K., Seitz S. et al.: "BRCA I mutations in german breast-cancer families". Int. J. Cancer, 1996, 68, 188.

[30] Hakansson S., Johannsson 0. T., Johansson U. et al.: ·'Moderate frequency of BRCAI and BRCA2 germ-line mutations in Scandinavian familial breast cancer". Am. J. Hum. Genet., 1997, 60, 1068.

[31] Johannsson O. T., Ostermeyer E., Hakansson S. et al.: "Founding BRCA I mutations in Hereditary Breast and Ovarian Cancer in Southern Sweden". Am. J. Hum. Genet., 1996, 58, 441.

[32] Serova-Sinilnikova O., Boutrand L., Stoppa-Lyonnet D. et al: "BRCA2 mutations in hereditary breast and ovarian cancer in France". Am. J, Hum, Genet., 1997, 60, 1236.

[33] Ramus S. J., Kote-Jarai Z., Friedman L. S. et al.: "Analysis of BRCAI and BRCA2 in Hungarian families with Breast or BreastOvarian cancer". Am. J. Hum. Genet., 1997, 60, 1242.

[34] Gao Q., Neuhausen S., Cummings S., Luce M.. Olopade O. I.: "Recurrent Germ-line BRCAI mutations in extended African American families with early-onset breast cancer". Am. J. Hum Genet., 1997. 60, 1233.

[35] Brind J., Chinchilli V. M., Severs W. B., Summy-Long J.: "lnduced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis''. J. Epidemiol. Community Health, 1996, 50, 481.

[36] Melbye M., Wohlfahrt J.. Olsen J. H. et al.: "Induced abortion and the risk of breast cancer". NE.J.M., 1997, 336, 81.

[37] Palmer J. R., Rosenberg L., Rao R. S. et al.: "Induced and spontaneous abortion in relation to risk of breast cancer (United States)". Cancer Causes and Control, 1997, 8, 841.

[38] Fioretti F., Tavani A.、Bosetti C. et al.: "Risk factors for breast cancer in nulliparous women". B1: J. Cancer, 1999, 79, 1923.

[39] Tavani A., Gallus S., La Vecchia C. et al.: "Risk factors for breast cancer in women under 40 years"．Eur. J. Cancer, 1999, 35, 1361.